Cardiac Filling Pressure:
At Your Fingertips.
Revolutionizing heart failure care with real-time, noninvasive insight into Pulmonary Capillary Wedge Pressure (PCWP), the best predictor of impending crisis.
Manage Heart Failure with a Trusted, Objective Hemodynamic Metric
Introducing the first and only heart failure monitoring solution to determine Pulmonary Capillary Wedge Pressure (PCWP) noninvasively at point-of-care, enabling clinicians to more precisely and proactively manage their patients.
Action Before Decompensation
Manage heart failure weeks before fluid builds up and symptoms arise.
A Quantitative Trend, Not Just a Notification
Optimize medical therapy with objective, longitudinal hemodynamic history.
Eliminate the Guesswork with Noninvasive Cardiac Filling Pressure
-
Rapid:
Quantitative PCWP readings available in minutes.
-
Easy-to-use:
CardioTag™ sensor deployable point-of-care at the bedside, in clinic, or at home.
-
Accurate:
FDA authorized and validated against right heart catheterization with accuracy on par with implantable sensors.
The CardioTag™ device and PCWP Analysis Software™ have been authorized to market as class II medical devices in the US.
Transform heart failure management at every step of the patient journey
Enabling timely clinical decision support to reduce heart failure hospitalizations and improve long-term patient outcomes through early detection and intervention.
ED Assessment & Triage
Rapidly evaluate heart failure at point-of-care to initiate medical therapy sooner to avoid hospitalization or shorten length-of-stay.
Inpatient Management & Discharge
Optimize medication protocols with ongoing PCWP assessment to reduce length-of-stay and discharge your patients with confidence.
Outpatient & At-Home
Monitor PCWP remotely and during follow-up outpatient visits to detect and treat worsening conditions and optimize guideline-directed medical therapy (GDMT).
Advancing AI to Transform Patient Care and Outcomes
Founded by engineers and scientists, Cardiosense leverages wearable technology, signal processing, and deep learning to diagnose and assess disease. Our AI platform converts raw physiological data into clinical intelligence, addressing complex cardiovascular challenges. We are now expanding to provide clinicians and patients with tools for precise, proactive heart failure management across all care settings.
Eric Meizlish
Chief Executive Officer
John D. Martin, MD, MBA, FACS
Chief Medical Officer
Omer Inan, PhD
Co-founder, Chief Scientific Officer
Andrew Carek, PhD
Co-founder, Chief Technical Officer
Amit Gupta
Co-founder, Chief Strategy Officer
Arezou Azar, PhD
Chief Regulatory & Compliance Officer
Mozziyar Etemadi, MD, PhD
Co-founder, Head of AI
Contact Us
Have a question? Connect with us here on product info, research opportunities, media inquiries, careers, or investor relations and a member of our team will reach out.
Start a conversation
No forms. Just tell us what you need.